Gimv leads EUR 10.3 million follow-on round to accelerate Itineris’ international growth

No Comments


Gimv leads EUR 10.3 million follow-on round to accelerate Itineris’ international growth

Gimv and Gimv managed Gimv Arkiv Tech Fund II jointly invest EUR 7.8 million in Itineris (, a Belgian software solutions company that has developed UMAX, a Microsoft-based software solution managing the meter-to-cash processes at utility companies. Next to Gimv, other existing investors PMV and CEO-founder Edgard Vermeersch jointly put EUR 2.5 million on top, lifting the total financing round to EUR 10.3 million.

With four clients in the US under contract, a strengthened leadership for the UMAX North American business, a geographical extension of its focus in Europe with several new customer wins and revenues topping EUR 43 million, 2016 was a key year for Itineris.

The funds will be used to further support the growth of the company. Next to investing in the improvement of its UMAX-solution for its existing customers, and extending its reach with new customers in both Europe and North-America, the company is also considering some acquisition opportunities.

After earlier financings in November 2013 and May 2015, this is the third investment round of Itineris in which Gimv acts as lead investor. It clearly shows Gimv’s willingness to provide larger financing tickets to ambitious entrepreneurs willing to scale up and accelerate the growth of their company in order to become  leading in their sector.

Categories: News


Partners Group and PSP Investments to acquire Cerba HealthCare, from PAI Partners

Partners Group, the global private markets investment manager, acting on behalf of its clients, and the Public Sector Pension Investment Board (“PSP Investments”), one of Canada’s largest pension investment managers, have agreed to acquire European medical laboratory services operator, Cerba HealthCare (“Cerba”, “the Company”). The company is being acquired from PAI Partners, a leading European private equity firm, and the company’s clinical pathologists and managers.

Founded in 1967 and headquartered in Paris, France, Cerba is a leading operator of clinical pathology laboratories, with a number one position in France and strong market positions in Belgium and Luxembourg. The majority of Cerba’s revenues are generated via routine lab tests. The company also focuses on specialty lab testing for more complex medical diagnoses and testing services for clinical trials. Cerba’s clients include private patients, physicians, labs, private and public hospitals, retirement and nursing homes, and pharmaceutical and biotech companies. The company employs almost 4,300 people, including 350 biologists, and generated revenues of approximately EUR 630 million in 2016.

Following the completion of the acquisition, which is subject to the legislative information process involving the Company’s works council and regulatory approvals, Partners Group and PSP Investments will work with Cerba’s management team, led by CEO Catherine Courboillet, to support the numerous growth opportunities of the business. These include the continuation of the Company’s highly successful M&A strategy within the French market and internationally, as well as the acceleration of organic growth and development in other segments.

Catherine Courboillet, CEO, Cerba HealthCare, states: “Cerba has enjoyed tremendous growth in the past decade. When we approached the transition to new ownership, we focused on finding partners who would not only support a continuation of this pace of growth, but could also bring valuable support in international development. We believe we have found the right partners in Partners Group and PSP Investments and look forward to working together with them to further build on Cerba’s market-leading position.”

Kim Nguyen, Managing Director, Private Equity Europe, Partners Group, comments: “Cerba is a resilient market leader in a highly attractive and fragmented sub-sector of the healthcare industry. The unique fully integrated business model means that Cerba is ideally positioned to further consolidate the French market and accelerate organic growth. We have been impressed by Catherine Courboillet’s strategy of entering new business areas and optimizing Cerba’s retail portfolio. We look forward to working together with Catherine and her team and our investment partner PSP Investments to continue strengthening Cerba’s market leadership position.”

Simon Marc, Managing Director, Private Equity (Europe), PSP Investments, adds: “Over the last couple of decades, Catherine Courboillet and her team have grown Cerba HealthCare into the leading private medical biology laboratory business in France. Cerba has developed a unique positioning in its markets on the back of its widely recognized medical and industry expertise and we are excited about the growth prospects of the company. As a provider of long-term strategic capital, we look forward to working with Partners Group, Catherine and the management team to support Cerba’s growth in France and internationally.”

Categories: News


Sunrise Capital II’s Asamiya Co., Ltd. merges with Meiwa Co., Ltd. to form LIFEDRINK COMPANY Inc.

No Comments

Tokyo, Monday 16 January, 2017

– CLSA Capital Partners, the alternative asset management arm of CLSA, is pleased to announce Sunrise Capital II ’s (“Sunrise II”) Asamiya Co., Ltd. (“Asamiya”), a low-cost beverage manufacturer headquartered in Osaka, and Meiwa Co., Ltd. (“Meiwa”), a beverage wholesaler headquartered in Tokyo, have reached an agreement to merge and form a new company, which will primarily focus on the sales and promotion of beverages and other food -related products.

Asamiya and Meiwa are expected to merge on March 1, 2017 and establish a new company named LIFEDRINK COMPANY Inc .(“LDC”) Sunrise II is a CLSA Capital Partners’ fund that invests in established, mid-cap companies with strong growth potential in Japan. Asamiya manufactures various food-related products with a key focus on beverages such as pet-bottled mineral water and tea. The company has nation-wide production facilities operating through its group’s subsidiaries and is renowned for its low-cost operations achieved through in-house integration of the value chain from procurement, manufacturing, logistics and distribution. To date, Asamiya has supplied safe and secure products to consumers at affordable prices mainly in West Japan.

On the other hand, Meiwa has been successful in identifying customer needs and has built a strong reputation as a reliable company for promoting and stably distributing safe and secure products sought -afterby customers, mainly in East Japan.Sunrise II believes that through the merger of the two companies, the newly established food/beverage-related promotion and distribution company, LDC, will be able to benefit from the strengths and synergies between Asamiya and Meiwa and will be capable of tapping an even wider client base through its affordable and sought-after products. In addition, Sunrise II believes that the merger will further optimise operations and contribute to building a stronger management platform, which will assist the company in further expanding the business. Sunrise II will continue to support further acceleration of growth in the newly established company, LDC.

About Sunrise Capital

Sunrise Capital is a Japan-dedicated private equity strategy, capitalising on opportunities in the mid-cap buyout sector. Sunrise Capital’s unique features include a hands-on approach and support with overseas expansion through CLSA’s global network. Sunrise Capital has completed investments in 10 companies to date and is assisting in realising their growth potential since its establishment in 2006.

About CLSA Capital Partners

CLSA Capital Partners is the alternative asset management arm of CLSA, Asia’s leading and longest-running brokerage and investment group. CLSA Capital Partners has more than US$3 billion under management and offices across the region, including Hong Kong, Singapore and Tokyo. CLSA Capital Partners offers a diversified and increasing range of investment strategies managed by a diverse team of industry professionals with expertise in private equity, banking and finance, law and accountancy and various industry specialisations.

For more information visit


Simone Wheeler

Global Head, Group Communications


T: +852 2600 8196


Mandy Ho

Senior Communications Manager


T: +852 2600 8193



Categories: News


IK Investment Partners to sell Colosseum Smile to Jacobs Holding AG


IK Investment Partners to sell Colosseum Smile to Jacobs Holding AG

IK Investment Partners (“IK”) is pleased to announce that the IK 2007 Fund has reached an agreement to sell Colosseum Smile Group, leading provider of private dental care in Scandinavia, to Jacobs Holding AG (“JAG”). Financial terms of the transaction are not disclosed.

Colosseum Smile Group was acquired by IK in 2010 and has since then accelerated its growth and consolidation of the Scandinavian dentistry market. Today Colosseum Smile is the leading provider of private dental care in Scandinavia with 52 clinics in Norway, Sweden and Denmark, offering a range of services from basic dental care to specialist surgery.

“Together with our employees and supported by IK, we have successfully developed Colosseum Smile from two smaller dentist chains to a high quality private dental care provider. We believe we have now reached a phase when we, together with JAG, will be able to take the next step in our development to reach our mission to be the best and most recognised Scandinavian provider of modern dental care for both customers and producers,” said David Halldén, CEO of Colosseum Smile.

Headquartered in Oslo, Colosseum Smile offers a full range of dental care services through its state of the art clinics across Scandinavia. The group has more than tripled in size since IK acquired Colosseum in Norway 2010 and merged Colosseum and Smile in Sweden in 2014.

Colosseum Smile has taken an active role in consolidating the fragmented dental care markets in Norway, Sweden and Denmark. Today the group’s sales amount to over 1.2 billion NOK.

”With numerous acquisitions and a merger, and together with Colosseum Smile’s management team, we have successfully transformed the company from an entrepreneurial endeavor to a leading chain in Scandinavia. The company is a first mover to integrate and consolidate the Scandinavian market, and is now ready to further leverage its platform,” said Thomas Klitbo, Partner at IK Investment Partners and advisor to the IK 2007 Fund.

“We are looking forward to acquire Colosseum Smile Group with its strong track record of delivering high quality care and offering excellent value to its patients and producers alike. We are excited to partner with the management team, and support them in their continuous efforts of building the leading dentistry chain in the Nordics,” said Tomas Aubell, Head of Investments at JAG.

The transaction is expected to close in the beginning of 2017.

For further questions, please contact:

Colosseum Smile
David Halldén, CEO
Phone: +46 708 441998

IK Investment Partners
Thomas Klitbo, Partner
Phone: +44 207 304 4300

Mikaela Hedborg
Communications & ESG Manager
Phone: +44 77 87 573 566

About Colosseum Smile
Colosseum Smile is Scandinavia’s largest private dental chain with 52 clinics in Norway, Sweden and Denmark. The group has more than 1,200 employees. W e are a dental chain with general dentists, dental hygienists, dental assistants and 90 leading specialists in all dental areas – all with the ambition to offer the best Nordic dentistry. Involvement, Innovative thinking and a holistic perspective form the cornerstones of Colosseum Smile’s values and guides us in how we conduct dental treatment and our aspiration to be the industry’s best workplace. For more information, please visit and

About IK Investment Partners
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €9 billion of capital and invested in over 100 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well positioned businesses with excellent long-term prospects. For more information, visit

About Jacobs Holding AG
JAG is a global professional investment firm based in Zurich and founded in 1994 by entrepreneur Klaus J. Jacobs. Its sole economic beneficiary is the Jacobs Foundation, one of the world’s leading charitable foundations dedicated to child and youth development. JAG has an established track record of holding its investment for long periods with the aim to successfully compete and become global market leaders in their respective fields. Previous and current investments include Jacobs Suchard AG, Adecco Group AG and Barry Callebaut AG. For more information, visit

Categories: News


Sale of Clean Surface Technology Co., Ltd.


Polaris Private Equity Fund III (“Polaris Fund III”), managed by Polaris Capital Group Co., Ltd. (“Polaris”), has agreed with Mitsui Matsushima Co., Ltd. on the sale of all of the shares of Clean Surface Technology Co., Ltd. (“CST”) (with 100% of the voting rights) owned by Polaris Fund III and other shareholder to Mitsui Matsushima Co., Ltd. and signed Share Purchase Agreement today.

Since its inception as Japan’s first specialist mask blank maker in 1977, CST has been manufacturing and distributing mask blank components to major photo mask manufacturers in Japan and abroad which in turn will be used to manufacture various end products such as LCDs, semiconductors and OLED and enjoys a high market share as one of the leading supplier in its field.

CST has accumulated globally top-notch technologies and know-hows through operating for many years within-house production of manufacturing machines/devices and secured a very high market shares in mask blanks for super-large LCDs and OLEDs. We expect a steady growth of the demand for mask blanks to be used in both LCDs and semi-conductors as well as a rowth of new market for super-large LCDs and OLEDs.

Polaris has decided to proceed with the sale since CST will be able to continue to grow by keeping its leading position in the mask blanks market through developing more advanced technologies and new products and accelerate its growth strategies as a core member of Mitsui Matsushima Group for creating a higher corporate value in the future.

The share transfer is expected to be completed on February 1, 2017.

For inquires:

Naohiko Ohno

Senior Vice President

Polaris Capital Group Co., Ltd.


Categories: News


AAC and management acquire organic pet food brand Yarrah from Vendis

AAC Logo

AAC Capital ( “AAC” ), a leading Benelux mid-market buyout firm, today announced the acquisition of Yarrah Organic Petfood B.V. ( “Yarrah” ) from Vendis Capital ( “Vendis” ). Yarrah is a leading European organic pet food brand with its headquarters in Harderwijk, the Netherlands. The management team of Yarrah, led by CEO Bas van Tongeren, will invest alongside AAC.

Yarrah is the leading organic pet food brand in Europe with a complete range of organic products for cats and dogs. All products are certified organic, which means all animal and plant ingredients need to live up to the highest quality restrictions to comply with the organic seal, meaning a.o. no exposure to chemical additives or preservatives, no use of hormones, but also maintaining high animal welfare standards for livestock used. The company supplies dry food (in bags) and wet food (both multi serve in cans and single serve in aluminium trays).

There is a trend towards pet owners feeding their cats and dogs organic food, driven by consumers who are becoming increasingly conscious of their own health and nutrition. Yarrah is ideally positioned to leverage on this trend as the European market leader in the organic pet food niche. Since Yarrah was founded in 1992, the company expanded its footprint beyond the Netherlands and currently serves health conscious pet owners in its core markets Germany, France and the Netherlands.

This is the fourth platform acquisition for AAC’s Benelux focussed Fund, and matches perfectly with AAC’s philosophy of supporting local champions in their growth ambitions.

Bas van Tongeren, CEO Yarrah, says:

“We are proud of the partnership with Vendis, through which we have successfully grown further in the organic market, and laid the foundation for our ambitions into pet specialty. In AAC we have found the perfect partner to support us in the next leg of our journey. The partnership with AAC will allow us to expand into upcoming organic markets and accelerate our expansion in the pet retail channel.”

Marc Staal, Chairman at AAC, says:

“Yarrah is operating in a growing ‘on-trend’ niche market as the European specialist in organic pet food. Bas van Tongeren and his team have a clear vision and philosophy: providing a healthy and sustainable pet food alternative to what is currently on offer in the market. Yarrah takes a leading role in pure organic pet food; food that’s not only better for pets, but for all animals. Yarrah’s view on its future business development, both in terms of geographies, distribution channels and new product development are well defined and being executed with high momentum. AAC is excited to be partnering with Yarrah and keen to facilitate Bas and his team to deliver upon their continuing growth ambitions.”

Michiel Deturck, Partner at Vendis, says:

“Yarrah is a leading brand operating in a fast-developing niche and we are very happy that Yarrah found a strong partner with AAC that can support the next growth phase of the company. We want to thank the management team for a very pleasant and successful partnership and wish the team all the best with its new partner.”



Notes to Editors

About AAC Capital

With offices in Amsterdam and Antwerp, AAC is a leading Benelux mid-market buy-out firm, which has to-date completed 30 management buyouts, of which 24 have been realised. It targets opportunities for majority stakes in profitable, cash-generative companies headquartered in the Benelux. AAC’s deal size is typically between €10 and €150 million, and it is currently investing from its third, Benelux focussed fund. AAC is a growth-oriented investor, with such companies in its portfolio as Desotec, Corilus, Lubbers Transport Group and Hobré Instruments.

About Vendis Capital

Vendis Capital is an independent private equity firm focused on building and investing in small to medium-sized branded consumer companies in Europe that are well positioned for value-creating growth or transformation. Vendis Capital aims to enter into partnerships with experienced entrepreneurs and managers to support the growth of their companies. The Vendis team operates out of 3 offices located in the Netherlands, Belgium and France.


For media enquiries, please contact:

Hill + Knowlton Strategies Nederland

Ariën Stuijt


T: +31 20 404 47 07


Categories: News


Eaton Vance completes acquisition of Calvert Investments

No Comments

Eaton Vance

Following the agreement reached for the purchase of SRI boutique Calvert Investments in October 2016, Eaton Vance has completed the acquisition of all business assets of Calvert Investments and has launched a new subsidiary, Calvert Research and Management.

Terms of the transaction were not disclosed.

Founded in 1976, Calvert Investments had $12.1bn (€11.6bn) of fund and separate account assets under management as of 31 October 2016.

John Streur, president and CEO of Calvert Investments, has joined Calvert Research and Management in the same role. He also retains his role of president of the Calvert Funds.

The Calvert Funds are diversified and responsibly invested mutual funds, encompassing actively and passively managed equity, fixed income and asset allocation strategies managed in accordance with the Calvert Principles for Responsible Investment.

“The new Calvert Research and Management is dedicated to building on the Calvert brand and legacy to achieve global leadership in responsible investment management,” said Thomas Faust, chairman and CEO of Eaton Vance.

Eaton Vance and its affiliates managed $336.4bn (€322.5bn) in assets as of 31 October 2016.

Categories: News


Erhvervsinvest sells Damolin to Imerys

The mineral company Damolin has been sold to Imerys – the world’s leading provider of mineral-based solutions to the industry. 


Erhvervsinvest has sold the Danish mineral company Damolin to France-based Imerys.

Damolin was founded in 1942 as Dansk Moler Industri A/S. The company’ main activities are minerals extraction and processing of minerals into products with a wide range of applications, such as absorption of oil and chemical spills, as a multi functional component in animal feed, and as cat litter. The products are primarily based on the highly unique mineral moclay, which is found only on the Danish islands of Fur and Mors.

Damolin’s headquarter is located on Fur, and the company has factories on Fur and Mors, as well as subsidiaries in France and Germany. Revenue in 2016 is expected to reach DKK 330 million, and the products are sold through Danish and European retail chains and distributors and directly to producers of animal feed and the industry. Damolin has 154 employees and has been owned by Erhvervsinvest and the company’s management since December 2010.


– ”Damolin has been a good investment for us, and we are proud of the development of the company during our ownership period. Together with the employees and management, we have made Damolin a leading player in Northern Europe with high profitability and a strong foundation in place for the journey ahead”, says Thomas Marstrand, Managing Partner in Erhvervsinvest.

Imerys is a publicly listed French company engaged in extraction and processing of minerals. The company supplies value-added solutions to a wide range of industries, from process industries to consumer goods. Imerys’ revenue in 2015 was EUR 4 billion, and Imerys has more than 16,000 employees across 250 industrial sites.

Categories: News

3i announces sale of Lekolar generating proceeds of c. £33 million


3i Group plc (“3i”), and funds managed by 3i, today announces that it has signed a preliminary agreement for the sale of Lekolar, the leading supplier of educational and learning material, furniture, toys, stationery, arts & crafts and playground materials to pre-schools and secondary schools in the Nordics to Nalka Invest AB.

The transaction is subject to the receipt of regulatory approvals as well as the satisfaction of customary closing conditions. Subject to these approvals, proceeds to 3i from today’s transaction will be c. £33m, a 17% increase on its September 2016 sterling valuation. The transaction is expected to complete in March 2017.

3i led the buyout of Lekolar in February 2007, investing in the largest platform in educational and pedagogical products in the Nordics. During 3i’s ownership, Lekolar has significantly strengthened its management team, broadened its offering and expanded its international reach.


For further information, contact:

3i Group plc
Silvia Santoro
Investor enquiries
Tel: +44 20 7975 3258

Toby Bates
Media enquiries
Tel: +44 20 7975 3032

Notes to editors:

About Lekolar

Lekolar is the leading supplier of educational and learning material, furniture, toys, stationery, arts & crafts and playground materials to pre-schools and secondary schools in the Nordics. The company is active in Norway, Denmark, Finland and Sweden. Lekolar is headquartered in Osby, Sweden and has a purchasing office in Shanghai. The company employs c.280 people.

About 3i Group

3i is an investment company with two complementary businesses, Private Equity and Infrastructure, specialising in core investment markets in Northern Europe and North America. For further information, please visit:

Regulatory information

This transaction involved a recommendation of 3i Investments plc, advised by 3i Sweden.

Categories: News